Oncología

Resultados: 452
Tipo Título / Nombre Autor(es) Año
Effectiveness and Safety of Cabozantinib Treatment in Patients with Advanced Renal Cell Carcinoma in Spanish and Portuguese Real-world Practice: The SOGUG-SPRWEC Study Suárez C, Reig Torras Ò, Morales Barrera R, Anguera Palacios G..., Collado Martín R, et al 2025
Treatment outcomes in patients with advanced mucosal melanoma in Spain: results from the real-world GEM1801 study Cerezuela-Fuentes P, Aguado de la Rosa C, Crespo G, Berciano-Guerrero MÁ, Soria A..., Ayala de Miguel P, et al 2025
Poor efficacy of anti PD-1 antibody based immunotherapy in patients with acral melanoma: results from the Spanish Melanoma Group (GEM) registry Gonzalez-Cao M, Berciano-Guerrero MÁ, Muñoz-Couselo E, Manzano JL..., Ayala de Miguel P 2025
Retreatment and rechallenge with BRAF/MEK inhibitors in patients with metastatic melanoma: results from the real-world Spanish Melanoma Registry (GEM-1801) Ayala-de Miguel P, Muñoz-Couselo E, Gutiérrez-Sanz L, Fernández LA, Navarro-Pérez V, Berciano-Guerrero MÁ, et al 2025
Ipatasertib combined with non-taxane chemotherapy for patients with previously treated advanced triple-negative breast cancer: the PATHFINDER phase IIa trial López-Miranda E, Pérez-García JM, Gión M, Ribelles N, Cortez-Castedo P..., González-Santiago S, et al 2025
Real-World Data on Immune-Checkpoint Inhibitors in Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Retrospective Study Del Corral-Morales J, Ayala-de Miguel C, Quintana-Cortés L, Sánchez-Vegas A, Aranda-Bellido F, González-Santiago S, et al 2025
Transcriptomic Predictors of Survival for Palbociclib + Endocrine Therapy Versus Capecitabine in Aromatase Inhibitor-Resistant Breast Cancer From the GEICAM/2013-02 PEARL Trial Agrawal YN, Fernández-Martínez A, Gil-Gil M, Zielinski C, Ruiz-Borrego M..., González-Santiago S, et al 2025
Molecular and immune profiling of breast cancer from pregnancy to postpartum: Insights into the tumour-immune landscape during breastfeeding from GEICAM EMBARCAM study Peña Enriquez R, Bermejo B..., López de Ceballos MH 2025
Impact of targeted therapies (TT) and immunotherapy (IO) on outcomes in patients (pts) with anaplastic thyroid carcinoma (ATC): International data from the Spanish GETNE registry Hernando J, Nunes T..., Ayala de Miguel P 2025
Remote physiologic and behavioral monitoring to predict early treatment response in metastatic cancer: High-Definition Oncology study (HDOs) preliminary results Paz Arbeizar L, Sauras M..., Santiago González S 2025